Literature DB >> 31376180

Celecoxib-induced bullous fixed drug eruption: An unusual presentation.

Helmi Ammar1, Nadia Ben Fredj1, Najeh Ben Fadhel1, Zohra Chadli1, Haifa Ben Romdhane1, Naceur A Boughattas1, Amel Chaabane1, Karim Aouam1.   

Abstract

Entities:  

Keywords:  bullous fixed drug eruption; celecoxib; oral rechallenge

Year:  2019        PMID: 31376180      PMCID: PMC6848903          DOI: 10.1111/bcp.14072

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations.

Authors:  W Aberer; A Bircher; A Romano; M Blanca; P Campi; J Fernandez; K Brockow; W J Pichler; P Demoly
Journal:  Allergy       Date:  2003-09       Impact factor: 13.146

2.  Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.

Authors:  Pedro Andrade; Margarida Gonçalo
Journal:  Contact Dermatitis       Date:  2011-02       Impact factor: 6.600

3.  Multifocal fixed drug eruption due to celecoxib.

Authors:  Veronica Bellini; Luca Stingeni; Paolo Lisi
Journal:  Dermatitis       Date:  2009 May-Jun       Impact factor: 4.845

4.  Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugs.

Authors:  C Defrance; P-J Bousquet; P Demoly
Journal:  Allergy       Date:  2011-07-04       Impact factor: 13.146

5.  Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation.

Authors:  M Kleinhans; L Linzbach; S Zedlitz; R Kaufmann; W-H Boehncke
Journal:  Contact Dermatitis       Date:  2002-08       Impact factor: 6.600

Review 6.  Fixed drug eruptions. Incidence, recognition, and avoidance.

Authors:  A Y Lee
Journal:  Am J Clin Dermatol       Date:  2000 Sep-Oct       Impact factor: 7.403

7.  Fixed drug eruption by etoricoxib confirmed by patch test.

Authors:  Aline Soares de Sousa; José Carlos Cardoso; Miguel Pinto Gouveia; Ana Rita Gameiro; Vera Barreto Teixeira; Maria Gonçalo
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

8.  Multifocal Fixed Drug Eruption with COX-2 Inhibitor-Celecoxib.

Authors:  Shikha Chugh; Rashmi Sarkar; Vijay K Garg; Avninder Singh; Chitralekha Keisham
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.